Downregulates ID2 phosphorylation. Elevated expression of DYRK1 drives ID2 Thr27 phosphorylation, decreases HIF2α stability, and inhibits glioma cell growth and loss of tumor stem cells. Here, DYRK1A is linked to central nervous system cancer.